Bone densitometry and bone biopsy

Stuart H Ralston
Best Practice & Research. Clinical Rheumatology 2005, 19 (3): 487-501
Bone densitometry is one of the most frequently used investigations in the assessment and management of patients suspected to have osteoporosis. The current method of choice for measuring BMD is dual-energy X-ray absorptiometry, because of its high precision and low radiation dose. The initiation and choice of treatment in patients with osteoporosis is critically dependent on the availability of BMD measurements and BMD can also be used to monitor the response to therapy. Transiliac bone biopsy is indicated for selected patients with metabolic bone disease where less invasive investigations have yielded inconclusive results. Under these circumstances it is an invaluable investigation that can be used to differentiate infiltrative disorders from primary abnormalities of osteoblast or osteoclast function.

Full Text Links

Find Full Text Links for this Article


You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

Remove bar
Read by QxMD icon Read

Save your favorite articles in one place with a free QxMD account.


Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.